Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Saint Etienne
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Histologically proved infiltrating breast cancer (ductal, lobular carcinoma…) or a carcinoma in-situ with an elevated risk of micro-invasion. (High grade with necrosis, radiologically evaluated size more than 40mm, or immediate mastectomy…)
Unifocal or multifocal but in same quarter
Size \< 5cm clinically palpable or not
Clinically or ultrasound axillary N0
Isotopic sentinel node detection
Adult patient
Signed informed consent by patient or legally responsable authority
Patient registered to a social security system
No surgical contra-indication
You may not be if
Mammary carcinoma recurrence
Previous same side mammary reduction
Previous lumpectomy
Contra-indication to surgery
Pregnant or breast feeding patient
Denial of participation
Clareo Health | Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer
